Granitero- Granisetron Inejction

Get a Price/Quote

MOQ : 100 Boxes

Granitero- Granisetron Inejction Specification

Indication
Prevention and treatment of nausea and vomiting caused by chemotherapy, radiotherapy, and surgery

Salt Composition
Granisetron Hydrochloride

Dosage Form
Injection

Feature
Other

Ingredients
Other

Application
Other

Ph Level
Neutral (Close to 7.0)

Physical Color/Texture
Clear, colorless solution

Storage Instructions
Store below 25°C, protect from light

Shelf Life
24 months

Pack Size
Available in 1 ml and 3 ml ampoules/vials

Preservative Free
Yes

Interactions
Monitor with medications prolonging QT interval

Usage
As directed by a healthcare professional

Route of Administration
Intravenous or intramuscular

Packaging Type
Ampoule, tray box

Prescription Required
Yes

Warning
Not for self-medication

Strength
1 mg/ml

Registration
Complies with national and international regulatory standards

Granitero- Granisetron Inejction Trade Information

Minimum Order Quantity
100 Boxes

Supply Ability
1000 Boxes Per Month

Delivery Time
7 Days

About Granitero- Granisetron Inejction

Granitero-Granisetron Injection is an elite, customizable solution designed for optimum results in the prevention and treatment of nausea and vomiting triggered by chemotherapy, radiotherapy, or surgery. Formulated as a preservative-free and odorless, clear, colorless solution, it features a rapid onset and high efficacy, delivering valorous performance for classic and complex clinical needs. Available in 1 mg/ml strength with 1 ml and 3 ml ampoule or vial options, Granitero complies with stringent national and international regulatory standards. Only for intravenous or intramuscular use, on prescription. Store below 25C away from light.

Purpose and Material Features of Granitero Injection

Granitero-Granisetron Injection is specifically indicated for the prevention and treatment of nausea and vomiting in patients undergoing chemotherapy, radiotherapy, and surgical procedures. Its general use in oncology and post-operative care settings is supported by its optimum, preservative-free formulation. Rapid-acting and efficient, it is administered intravenously or intramuscularly. Each injection contains the active salt Granisetron Hydrochloride and is packaged in clear, colorless ampoules for enhanced safety and classic reliability within hospitals and clinics.

Export Supply and Market Reach of Granitero Injection

Granitero-Granisetron Injection is supplied and handed over via major FOB ports for global export. Our asking price is competitive for elite healthcare providers and distributors alike. Featured in both main export marketsAsia, Africa, and the Middle Eastand major domestic markets across India, Granitero guarantees timely, reliable delivery and meets varied clinical demands. We pride ourselves on upholding optimum quality and regulatory compliance in every batch supplied to international and national partners.

FAQs of Granitero- Granisetron Inejction:

Q: How is Granitero-Granisetron Injection administered?

A: Granitero Injection must be administered by a healthcare professional via intravenous or intramuscular injection, as indicated.

Q: What are the primary benefits of using Granitero-Granisetron Injection?

A: The injection provides rapid onset and high efficacy in preventing and treating nausea and vomiting associated with chemotherapy, radiotherapy, and surgery.

Q: When should Granitero-Granisetron Injection not be used?

A: It should not be used in individuals with known hypersensitivity to Granisetron or any components of the injection.

Q: Where should Granitero Injection be stored?

A: Granitero Injection should be stored below 25C, protected from light, and kept out of reach of unauthorized individuals.

Q: What process ensures the safety and quality of Granitero Injection?

A: Granitero complies with national and international regulatory standards, and each batch is packaged in ampoules or vials for hospital-grade safety.